Positive interim results from Phase I/II multiple myeloma cancer vaccine trial

被引：0
|
作者：
Riedmann, Eva M.
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2012年 / 8卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：696 / 697
页数：2
相关论文
共 50 条
  • [1] CART-ddBCMA for multiple myeloma: Interim results from phase I study
    Frigault, M.
    Rosenblatt, J.
    Raje, N.
    Cook, D.
    Gaballa, M.
    Emmanuel-Alejandro, E.
    Cornwell, C.
    Banerjee, K.
    Rotte, A.
    Heery, C.
    Avigan, D.
    Jakubowiak, A.
    Bishop, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S828 - S828
  • [2] Jenner Technologies reports results from phase I/II trial of prostate cancer vaccine
    不详
    DRUG NEWS & PERSPECTIVES, 1997, 10 (06) : 362 - 362
  • [3] ImMucin, anti-MUC1 therapeutic vaccine: an interim analysis from a phase I/II study in multiple myeloma patients
    Carmon, L.
    Kovjazin, R.
    Moran, O.
    Avivi, I.
    Dray, L.
    Shapira, M. Y.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S200 - S200
  • [4] MVA-MUC1-Il2 vaccine immunotherapy for MUC1-positive cancer: Phase I and interim phase II results
    Acres, B
    Christophe, R
    Figlin, R
    Maciejewska, T
    Mourot, B
    Squiban, P
    Faivre-Bizouarne, N
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S4 - S4
  • [5] Ovarian cancer vaccine candidate DPX-Survivac: positive interim results from phase 1
    Riedmann, Eva M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (12) : 1743 - 1743
  • [6] Positive Phase II interim data on AE37 cancer vaccine released
    Riedmann, Eva M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (02)
  • [7] A Phase I Trial of the Anti-Inhibitory KIR Antibody, IPH2101, and Lenalidomide in Multiple Myeloma: Interim Results
    Benson, Don M., Jr.
    Cohen, Adam D.
    Munshi, Nikhil C.
    Jagannath, Sundar
    Spitzer, Gary
    Hofmeister, Craig C.
    Zerbib, Robert
    Andre, Pascale
    Efebera, Yvonne A.
    Oxier, Shawna
    Caligiuri, Michael A.
    BLOOD, 2012, 120 (21)
  • [8] Lenalidomide, Adriamycin and Dexamethasone (RAD) As An Induction Regimen In Newly Diagnosed Multiple Myeloma-Interim Results From a German Multicenter Phase II Trial
    Knop, Stefan
    Langer, Christian
    Engelhardt, Monika
    Muegge, Lars O.
    Roesler, Wolf
    Reichle, Albrecht
    Roellig, Christoph
    Hertenstein, Bernd
    Gramatzki, Martin
    Bassermann, Florian
    Ostermann, Helmut
    Sturm, Isrid
    Ringhoffer, Mark
    Schaefer-Eckart, Kerstin
    Kraus, Sabrina
    Einsele, Hermann
    Bargou, Ralf C.
    BLOOD, 2013, 122 (21)
  • [9] Interim Results of a Phase I/II Clinical Trial of a DNA Plasmid Vaccine (BHT-3021) for Type 1 Diabetes
    Eisenbarth, George
    Colman, Peter
    Gottlieb, Peter
    Harrison, Leonard
    Quan, Joanne
    Roep, Bart
    Solvason, Nanette
    Steinman, Lawrence
    Garren, Hideki
    CLINICAL IMMUNOLOGY, 2009, 131 : S84 - S84
  • [10] Interim results of a phase I/II clinical trial of a DNA plasmid vaccine (BHT-3021) for type 1 diabetes
    Gottlieb, P.
    Eisenbarth, G.
    Harrison, L.
    Colman, P.
    Roep, B.
    Quan, J.
    Solvason, N.
    Steinman, L.
    Garren, H.
    DIABETOLOGIA, 2009, 52 : S83 - S83
12345